Acta Pharmaceutica Sinica B
|
2026, 16(3): 1769-1772
• Letters to the editor •
Single-cell RNA sequencing-guided drug discovery to alleviate radiotherapy-induced esophageal toxicity
Full
Wenling Tu1,2,3, Hangfeng Liu1, Hongyu Lin1,2, Jinkang Zhang1,2, Tang Feng4, Zhenyu Ding4, Qing Li4, Yuhong Shi1, Zehua Zhou1, Shuyu Zhang1,5,3
Affiliations
1 The Second Affiliated Hospital of Chengdu Medical College, Nuclear Industry 416 Hospital, Chengdu 610051, China;
2 School of Bioscience and Technology, Chengdu Medical College, Chengdu 610500, China;
3 NHC Key Laboratory of Nuclear Technology Medical Transformation (Mianyang Central Hospital), Mianyang 621099, China;
4 Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China;
5 Laboratory of Radiation Medicine, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu 610041, China
doi: 10.1016/j.apsb.2025.12.038
Outline
Radiotherapy-induced esophageal toxicity (RIET)
/
Single-cell RNA sequencing (scRNA-Seq)
/
Drug discovery
/
MAPK/NF-κB pathway
/
AP-1 transcription factor complex
/
T-5224
/
Metformin
/
Pleiotrophin (PTN)
Wenling Tu, Hangfeng Liu, Hongyu Lin, Jinkang Zhang, Tang Feng, Zhenyu Ding, Qing Li, Yuhong Shi, Zehua Zhou, Shuyu Zhang.
Single-cell RNA sequencing-guided drug discovery to alleviate radiotherapy-induced esophageal toxicity[J].
Acta Pharmaceutica Sinica B,
2026
, 16
(3)
: 1769
-1772
.
DOI: 10.1016/j.apsb.2025.12.038
Year 2026 volume 16 Issue 3
PDF
8
5
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.12.038
- Receive Date:2025-07-29
- Online Date:2026-09-17